CHARLWOOD PHARMA LIMITED

Active Hook

Wholesale of pharmaceutical goods

4 employees website.com
Wholesale of pharmaceutical goods
C

CHARLWOOD PHARMA LIMITED

Wholesale of pharmaceutical goods

Founded 17 Jul 2015 Active Hook, England 4 employees website.com
Wholesale of pharmaceutical goods
Accounts Due 30 Sept 2026 4 months remaining
Confirmation
Net assets £881K £257K 2024 year on year
Total assets £2M £494K 2024 year on year
Total Liabilities £629K £237K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Trotwood The Firs Odiham Hook Hampshire RG29 1PP England

Full company profile for CHARLWOOD PHARMA LIMITED (09691337), an active company based in Hook, England. Incorporated 17 Jul 2015. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2016–2024)

Cash in Bank

£475.22k

Decreased by £94.91k (-17%)

Net Assets

£881.33k

Increased by £256.52k (+41%)

Total Liabilities

£628.57k

Increased by £237.01k (+61%)

Turnover

N/A

Employees

4

Debt Ratio

42%

Increased by 3 (+8%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 4 Shares £4 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Apr 20201£1£1
2 Apr 20201£1£1
13 Jul 20161£1£1
13 Jul 20161£1£1

Officers

Officers

3 active
Status
Condon, Richard MichaelDirectorBritishEngland491 Oct 2025Active
Lisa Jane PotterDirectorBritishEngland571 Nov 2018Active
William David PotterDirectorBritishEngland5817 Jul 2015Active

Shareholders

Shareholders (4)

Andrew Farrant
25.0%
William David Potter
25.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Aspire Pharma Limited

Unknown

Active
Notified 1 Oct 2025
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Eleanor Margaret Craig Farrant

Ceased 2 Apr 2020

Ceased

William David Potter

Ceased 2 Apr 2020

Ceased

Group Structure

Group Structure

CHARLWOOD PHARMA LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Oct 2025Persons With Significant ControlWithdrawal Of A Person With Significant Control Statement
3 Oct 2025Persons With Significant ControlAspire Pharma Limited notified as a person with significant control
2 Oct 2025OfficersTermination of Eleanor Margaret Craig Farrant as director on 1 Oct 2025
2 Oct 2025OfficersTermination of Andrew David Farrant as director on 1 Oct 2025
2 Oct 2025OfficersTermination of William David Potter as director on 1 Oct 2025
3 Oct 2025 Persons With Significant Control

Withdrawal Of A Person With Significant Control Statement

3 Oct 2025 Persons With Significant Control

Aspire Pharma Limited notified as a person with significant control

2 Oct 2025 Officers

Termination of Eleanor Margaret Craig Farrant as director on 1 Oct 2025

2 Oct 2025 Officers

Termination of Andrew David Farrant as director on 1 Oct 2025

2 Oct 2025 Officers

Termination of William David Potter as director on 1 Oct 2025

Recent Activity

Latest Activity

Withdrawal Of A Person With Significant Control Statement

7 months ago on 3 Oct 2025

Aspire Pharma Limited notified as a person with significant control

7 months ago on 3 Oct 2025

Termination of Eleanor Margaret Craig Farrant as director on 1 Oct 2025

7 months ago on 2 Oct 2025

Termination of Andrew David Farrant as director on 1 Oct 2025

7 months ago on 2 Oct 2025

Termination of William David Potter as director on 1 Oct 2025

7 months ago on 2 Oct 2025